P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA

• DOI: 10.1097/01.hs9.0000846616.21003.5d
• Publication Date: 2022-06-23T17:00:13Z
• Authors: M. S. Raab; Y. C. Cohen; F. Schjesvold; K. Aardalen; A. Oka; A. Spencer; M. Wermke; P. Hari; J. L. Kaufman; A. M. Cafro; E. M. Ocio; N. Doki; K. Henson; G. Trabucco; P.-E. Juif; R. Chawla; J. Cotton; A. Fessehatsion; L. Fan; J. Blankenship; B. Granda; H. Lu; S. De Vita
• Keywords: 0301 basic medicine; 03 medical and health sciences; Posters; Diseases of the blood and blood-forming organs; RC633-647.5